Founded in 2014, Biorelate is a start-up and has done particularly well to generate revenue so early into its existence. The Company’s technology combines natural language processing and AI with human expert curation to generate highly relevant output from unstructured big data. Uses of Biorelate’s technology include curation and exploration of unused sources of knowledge of molecular mechanisms for drug discovery, tracking specific biomedical developments, expertise sourcing and competitive intelligence.

Having spent a year in a beta phase commercialising the founder’s PhD work at the University of Manchester on big data computational analysis, the business is experiencing strong demand for its services, including a recent collaboration deal signed with an AIM listed drug-discovery specialist.  CEO Daniel Jamieson has a background in biology and bioinformatics and founded the business while completing his PhD at the University of Manchester after successfully prototyping a highly efficient and accurate method of disease curation.

Biorelate will use the funding to grow the team and to develop its product offering, including three new SaaS products.

Could NPIF Maven Equity Finance help fund your growth journey?

If you’re running a business that’s looking to grow, we’d love to hear from you. Feel free to give us a call to find out more about our flexible funding solutions:

0191 731 8595